Carotid Artery Perivascular Adipose Tissue Density and Response to Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke

被引:2
|
作者
Gencer, Elif Sarionder [1 ,2 ]
Yilmaz, Ezgi [1 ]
Arsava, Ethem Murat [1 ]
Gocmen, Rahsan [3 ]
Topcuoglu, Mehmet Akif [1 ,4 ]
机构
[1] Hacettepe Univ, Fac Med Hosp, Dept Neurol, Ankara, Turkiye
[2] Univ Hlth Sci, Antalya Training & Res Hosp, Dept Neurol, Antalya, Turkiye
[3] Hacettepe Univ, Fac Med Hosp, Dept Radiol, Ankara, Turkiye
[4] Hacettepe Univ, Sch Med, Dept Neurol, TR-06230 Ankara, Turkiye
关键词
carotid; inflammation; thrombolysis; atherosclerosis; artery-to-artery embolism; perivascular adipose tissue; COMPUTED-TOMOGRAPHY; INFLAMMATION; ASSOCIATION; ATHEROSCLEROSIS; REPRODUCIBILITY; THROMBOLYSIS; BIOMARKERS; STENOSIS; SCORE;
D O I
10.1177/00033197231174654
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The importance of Carotid Artery Perivascular Adipose Tissue Density (CAPATd), a parameter that can be readily evaluated on emergency computed tomographic angiography (CTA), in acute stroke has not been adequately clarified. We created exploratory logistic regression models to detect the interaction between the effect of CAPATd and intravenous (IV) tissue plasminogen activator (tPA) in 174 patients (mean age 71 +/- 14 years, 94 women) with acute ischemic stroke treated with IV-tPA alone. The CAPATd-average mean (-60.6 +/- 18.7 vs -89.8 +/- 25.3 Hounsfield units (HU), P = .002) and CAPATd-maximum (14.8 +/- 68.9 vs -20.5 +/- 39.8 HU, P = .020) values were higher on the ipsilateral side of carotid artery stenosis >60%. CAPATd-maximum ipsilateral emerged as an independent predictor for both modified Rankin's Score 0-2 (52%) [exp(beta) = .984] and mRS 0-1 outcome (32%) [exp(beta) = .828] in addition to admission National Institutes of Health Stroke Scale, age and carotid plaque burden. CAPATd-maximum ipsilateral was acceptably accurate (Area under the Receiver operating characteristic Curve was .607, P = .0109 for mRS 0-2 and .613, P = .0102 for mRS 0-1). Ipsilateral CAPATd >= -25 HU predicted both mRS >3 and mRS >2 with usable sensitivity (59.8% and 66.07%) and specificity (63.6% and 59.68%). In conclusion, higher maximum CAPATd measured on emergency CTA indicates poorer functional prognosis in acute stroke patients treated with IV-tPA.
引用
收藏
页码:472 / 479
页数:8
相关论文
共 50 条
  • [1] Utilization of intravenous tissue plasminogen activator for acute ischemic stroke
    Katzan, IL
    Hammer, MD
    Hixson, ED
    Furlan, AJ
    Abou-Chebl, A
    Nadzam, DM
    [J]. ARCHIVES OF NEUROLOGY, 2004, 61 (03) : 346 - 350
  • [2] Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion
    Christou, I
    Felberg, RA
    Demchuk, AM
    Burgin, WS
    Malkoff, M
    Grotta, JC
    Alexandrov, AV
    [J]. JOURNAL OF NEUROIMAGING, 2002, 12 (02) : 119 - 123
  • [3] Carotid Artery Stenting for Acute Ischemic Stroke Patients after Intravenous Recombinant Tissue Plasminogen Activator Treatment
    Deguchi, Ichiro
    Hayashi, Takeshi
    Neki, Hiroaki
    Yamane, Fumitaka
    Ishihara, Shoichiro
    Tanahashi, Norio
    Takao, Masaki
    [J]. INTERNAL MEDICINE, 2016, 55 (19) : 2869 - 2872
  • [4] Thrombotic occlusion of the common carotid artery (CCA) in acute ischemic stroke treated with intravenous tissue plasminogen activator (TPA)
    Sharma, V. K.
    Tsivgoulis, G.
    Lao, A. Y.
    Flaster, M.
    Frey, J. L.
    Malkoff, M. D.
    Alexandrov, A. V.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (02) : 237 - 240
  • [5] Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
    Fugate, Jennifer E.
    Rabinstein, Alejandro A.
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (07) : 960 - 972
  • [6] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
  • [7] Safety and efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Rajapa, S.
    Sivakumar, S.
    Arjundas, D.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 133 - 133
  • [8] The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke
    Kahn, JH
    Viereck, J
    Kase, C
    Jeerakathil, T
    Romero, R
    Mehta, SD
    Kociol, R
    Babikian, V
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2005, 29 (03): : 273 - 277
  • [9] INTRAVENOUS RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE CAROTID-ARTERY TERRITORY STROKE
    MORI, E
    YONEDA, Y
    TABUCHI, M
    YOSHIDA, T
    OHKAWA, S
    OHSUMI, Y
    KITANO, K
    TSUTSUMI, A
    YAMADORI, A
    [J]. NEUROLOGY, 1992, 42 (05) : 976 - 982
  • [10] Tissue plasminogen activator for acute ischemic stroke
    Qureshi, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21): : 1406 - 1406